BeStock  
Stocks › Biotechnology › STOK

Stoke Therapeutics STOK

US equityMarket cap rank #2770Biotechnology
$26.81 −$0.12 (-0.45%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.40 +2.20%
Open$26.39
Prev close$26.93
Day range$25.94 – $27.78
Volume615.8K
Market cap$1.75B
P/E (TTM)–
Dividend yield–

STOK Stock News

Headlines matching Stoke Therapeutics or the STOK ticker, most recent first.

  • A Quick Look at Today's Ratings for Stoke Therapeutics(STOK.US), With a Forecast Between $40 to $60Market news · 5 Aug 2026 · Direct mention
  • Analysts Are Bullish on These Healthcare Stocks: Stoke Therapeutics (STOK), Fortrea Holdings Inc. (FTRE) PositiveTipRanks · 4 Aug 2026 · Direct mention
  • Chardan Capital Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $35Market news · 4 Aug 2026 · Direct mention
  • J.P. Morgan Upgrades Stoke Therapeutics(STOK.US) to Buy Rating, Raises Target Price to $40 PositiveMarket news · 21 Aug 2026 · Direct mention
  • CCORF Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $58Market news · 13 Aug 2026 · Direct mention
  • Needham Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $40Market news · 9 Jul 2026 · Direct mention
  • Jefferies Initiates Stoke Therapeutics(STOK.US) With Buy Rating, Announces Target Price $44Market news · 14 Jul 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK), Genelux Corp. (GNLX) and Celldex (CLDX)TipRanks · 9 May 2026 · Direct mention
  • A Quick Look at Today's Ratings for Stoke Therapeutics(STOK.US), With a Forecast Between $38 to $60Market news · 9 May 2026 · Direct mention
  • TD Cowen Maintains Stoke Therapeutics(STOK.US) With Buy RatingMarket news · 8 May 2026 · Direct mention
  • Guggenheim Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $60Market news · 8 May 2026 · Direct mention
  • BTIG Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $39Market news · 11 May 2026 · Direct mention
  • H.C. Wainwright Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $50Market news · 22 Apr 2026 · Direct mention
  • CCORF Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Raises Target Price to $60 PositiveMarket news · 20 Mar 2026 · Direct mention
  • Wedbush Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $38Market news · 18 Mar 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on STOK.

Sign in to join the discussion.

Scroll to Top